The head of the U.S. Justice Department’s antitrust division, speaking at a Senate hearing, didn’t rule out the department starting another probe of Google Inc.’s business practices if new allegations emerge.
U.S. antitrust regulators are investigating whether Macquarie Group Ltd.’s private-equity arm violated a consent decree allowing it to buy the Advantage rental car brand from Hertz Global Holdings Inc., two people familiar with the matter said.
For more than a decade, drugmakers have battled U.S. Federal Trade Commission accusations that they have colluded to forestall the introduction of dozens of generic medicines, costing buyers as much as $3.5 billion a year.
Online companies may face action by Congress to toughen U.S. privacy standards if they don’t do a better job of protecting the privacy of mobile device users, Federal Trade Commission Chairman Jon Leibowitz said today.
The U.S. Supreme Court agreed to take up a multibillion-dollar fight between the drug industry and federal antitrust enforcers, a case that may determine how quickly low-price generic medicines reach the market.
A multibillion-dollar fight between the drug industry and antitrust enforcers is poised to get U.S. Supreme Court review in a case that may determine how quickly low-price generic medicines reach the market.
U.S. Federal Trade Commission Chairman Jon Leibowitz took time away from a Southern California technology conference to dine with a senior executive at Google Inc., the subject of an intensifying government antitrust probe.